Metraipolis › archive › dc_26b4eef2bd6a

Inclisiran SiRNA therapy for durable LDL-C reduction: a systematic review and meta-analysis highlighting a breakthrough in long-term cardiovascular risk… — Europe PMC PMID:41514239

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41514239
DOI: 10.1186/s12872-[numero omesso]-3
License (as archived): solo-consultazione
Archived: 2026-11-06T22:17:53.297Z
SHA-256 of the archived text: ca74674833e997560d2ebca08ca4ad1101168886285aed0fb542a0eb7d761031
Stable URL of this page: https://metraipolis.com/documento/dc_26b4eef2bd6a

How to cite

Inclisiran SiRNA therapy for durable LDL-C reduction: a systematic review and meta-analysis highlighting a breakthrough in long-term cardiovascular risk… — Europe PMC PMID:41514239 — Europe PMC (en), https://europepmc.org/article/MED/41514239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_26b4eef2bd6a (Metraipolis archive dc_26b4eef2bd6a, sha256 ca74674833e997560d2ebca08ca4ad1101168886285aed0fb542a0eb7d761031)

BibTeX

@misc{dc26b4eef2bd6a,
  title = {Inclisiran SiRNA therapy for durable LDL-C reduction: a systematic review and meta-analysis highlighting a breakthrough in long-term cardiovascular risk… — Europe PMC PMID:41514239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41514239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_26b4eef2bd6a; sha256 ca74674833e997560d2ebca08ca4ad1101168886285aed0fb542a0eb7d761031},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514239. Agents can read the archived copy with the MCP tool read_document.